FRMM
Forum Markets, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$4.66
−2.82%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 10.8M | 6.5M | — | — | — |
| Cost of Revenue | 1.9M | — | 58.3K | 105.7K | — |
| Gross Profit | 8.9M | 6.5M | (58.3K) | (105.7K) | — |
| Operating Expenses | |||||
| R&D Expense | — | — | 2.0M | 2.8M | 2.4M |
| SG&A Expense | 253.5M | 240.0M | 4.4M | 10.7M | 15.5M |
| General & Admin Expense | 244.1M | 240.0M | 4.4M | 10.7M | 15.5M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 10.2M | — | (58.3K) | (105.7K) | — |
| Total Operating Expenses | 263.8M | 240.0M | 6.3M | 13.4M | 17.9M |
| Cost and Expenses | 265.7M | 240.0M | 6.3M | 13.5M | 17.9M |
| Operating Income (EBIT) | (254.9M) | (233.4M) | (6.3M) | (13.5M) | (17.9M) |
| Non-Operating | |||||
| Interest Income | 4.6M | 4.5M | — | — | 1.5K |
| Interest Expense | 4.3M | 3.1M | 50.6K | 44.83 | 28.2K |
| Net Interest Income | 342.1K | 1.5M | (50.6K) | (44.83) | (26.7K) |
| Other Non-Op Income/Expense | (275.3M) | (210.1M) | (139.5K) | (8.8M) | (21.8M) |
| Non-Operating Income (excl Interest) | 268.7M | 207.0M | 190.1K | 8.8M | 21.7M |
| EBT (Pre-Tax Income) | (530.1M) | (443.5M) | (6.5M) | (22.3M) | (39.7M) |
| Income Tax Expense | — | — | (296.0K) | (2.3M) | (942.7K) |
| Bottom Line | |||||
| Net Income | (527.4M) | (450.5M) | (6.2M) | (19.9M) | (38.7M) |
| Earnings from Cont. Ops | (530.1M) | (443.5M) | (6.2M) | (19.9M) | (38.7M) |
| Earnings from Discont. Ops | 2.7M | (7.0M) | — | — | — |
| Bottom Line Net Income | (527.4M) | (450.5M) | (14.2M) | (19.9M) | (38.7M) |
| Per Share | |||||
| Basic EPS | ($33.17) | ($55.18) | ($154.90) | ($526.00) | ($3,872.60) |
| Diluted EPS | ($33.17) | ($55.18) | ($154.90) | ($525.90) | ($3,871.80) |
| Revenue Per Share | $0.63 | $0.80 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 17.1M | 8.2M | 91537 | 37900 | 10000 |
| Diluted Shares Outstanding | 17.1M | 8.2M | 91537 | 37909 | 10000 |
| Profitability Metrics | |||||
| EBITDA | (522.2M) | (440.5M) | (6.3M) | (22.1M) | (39.5M) |
| D&A | 1.4M | — | 190.1K | 105.7K | 109.0K |
| EBIT | (523.6M) | (440.5M) | (6.5M) | (22.2M) | (39.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026